Hang G. Qian
183 Xinqiao Street
Xinqiao, 400037, China
Xinqiao, 400037, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Corrigendum to "The current situation of intensive care units in Chinese mainland: A nationwide survey" [Journal of Intensive Medicine volume 2 (2026) 132-140].
Journal: Journal of intensive medicine
Published: July 03, 2026
Bioinformatics Screening and Preliminary Experimental Verification of Integrated Stress Response-Associated MYC and BAG3 in Chronic Obstructive Pulmonary Disease.
Journal: International journal of chronic obstructive pulmonary disease
Published: April 10, 2026
Dual-Modal Phototherapeutic Nanoagents Eradicating Drug-Resistant Bacteria via Multi-Pathway of Membrane Disruption, Oxidative Damage, and Energy Metabolism Interference.
Journal: Advanced healthcare materials
Published: March 30, 2026
Rab26 mitigates ferroptosis in airway epithelium induced by cigarette smoke through suppression of VDAC1 oligomerization-mediated cGAS-STING activation.
Journal: Free radical biology & medicine
Published: February 23, 2026
Immunomodulatory effect of borax on murine hepatocellular carcinoma induced by diethylnitrosamine.
Journal: Scientific reports
Published: January 27, 2026
Aptamer-guided upconversion nanoconstructs enable proximity-dependent and precise photodynamic therapy for MRSA-infected wounds.
Journal: Materials today. Bio
Published: January 12, 2026
Rab32-mediated macrophage apoptosis and apoptotic body release promote M1 polarization in ARDS via the Cxcl11/Ccl4/NF-κB pathway.
Journal: International immunopharmacology
Published: January 09, 2026
Rab43 mitigates the inflammatory response in acute lung injury via MyD88 ubiquitination.
Journal: Scientific reports
Published: October 26, 2025
A Network Analysis of the Interrelationships Between Depression, Anxiety, Insomnia and Non-Suicidal Self-Injury in Middle School Students.
Journal: Psychology research and behavior management
Published: October 16, 2025
Efficacy and Safety of Escitalopram in Alleviating Depression and Anxiety Symptoms in COPD Patients: A Randomized Double-Blind Placebo-Controlled Trial.
Journal: International journal of chronic obstructive pulmonary disease
Published: October 08, 2025
Last Updated: 09/26/2026